Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Bangsberg

Showing results (371-380 of 390) with videos related to

Pageof 39
Sort By:
Journal of Virology|October 12, 2018
Genotypic and Mechanistic Characterization of Subtype-Specific HIV Adaptation to Host Cellular ImmunityNatalie N Kinloch, Guinevere Q Lee, Jonathan M Carlson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 9, 2007
Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries, , Martin W G Brinkhof, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 24, 2014
An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in UgandaChristina Psaros, Jessica E Haberer, Elly Katabira, et al.
Journal of the International AIDS Society|February 13, 2019
ART adherence and viral suppression are high among most non-pregnant individuals with early-stage, asymptomatic HIV infection: an observational study from Uganda and South AfricaJessica E Haberer, Bosco M Bwana, Catherine Orrell, et al.
Plos Medicine|February 16, 2023
High PrEP uptake and objective longitudinal adherence among HIV-exposed women with personal or partner plans for pregnancy in rural Uganda: A cohort studyLynn T Matthews, Esther C Atukunda, Moran Owembabazi, et al.
The Journal of Infectious Diseases|September 9, 2015
Persistent Immune Activation and Carotid Atherosclerosis in HIV-Infected Ugandans Receiving Antiretroviral TherapyMark J Siedner, June-Ho Kim, Ruth Sentongo Nakku, et al.
AIDS (London, England)|February 26, 2021
Pre-treatment integrase inhibitor resistance is uncommon in antiretroviral therapy-naive individuals with HIV-1 subtype A1 and D infections in UgandaSuzanne M McCluskey, Kimia Kamelian, Nicholas Musinguzi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 6, 2015
Super Learner Analysis of Electronic Adherence Data Improves Viral Prediction and May Provide Strategies for Selective HIV RNA MonitoringMaya L Petersen, Erin LeDell, Joshua Schwab, et al.
Journal of Virology|May 8, 2020
Differential Vpu-Mediated CD4 and Tetherin Downregulation Functions among Major HIV-1 Group M SubtypesGisele Umviligihozo, Kyle D Cobarrubias, Sandali Chandrarathna, et al.
Journal of the International AIDS Society|September 30, 2011
Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009Elvin H Geng, Peter W Hunt, Lameck O Diero, et al.
Pageof 39

Showing results (371-380 of 390) with videos related to

Sort By:
Pageof 39
Journal of Virology|October 12, 2018
Genotypic and Mechanistic Characterization of Subtype-Specific HIV Adaptation to Host Cellular ImmunityNatalie N Kinloch, Guinevere Q Lee, Jonathan M Carlson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 9, 2007
Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries, , Martin W G Brinkhof, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 24, 2014
An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in UgandaChristina Psaros, Jessica E Haberer, Elly Katabira, et al.
Journal of the International AIDS Society|February 13, 2019
ART adherence and viral suppression are high among most non-pregnant individuals with early-stage, asymptomatic HIV infection: an observational study from Uganda and South AfricaJessica E Haberer, Bosco M Bwana, Catherine Orrell, et al.
Plos Medicine|February 16, 2023
High PrEP uptake and objective longitudinal adherence among HIV-exposed women with personal or partner plans for pregnancy in rural Uganda: A cohort studyLynn T Matthews, Esther C Atukunda, Moran Owembabazi, et al.
The Journal of Infectious Diseases|September 9, 2015
Persistent Immune Activation and Carotid Atherosclerosis in HIV-Infected Ugandans Receiving Antiretroviral TherapyMark J Siedner, June-Ho Kim, Ruth Sentongo Nakku, et al.
AIDS (London, England)|February 26, 2021
Pre-treatment integrase inhibitor resistance is uncommon in antiretroviral therapy-naive individuals with HIV-1 subtype A1 and D infections in UgandaSuzanne M McCluskey, Kimia Kamelian, Nicholas Musinguzi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 6, 2015
Super Learner Analysis of Electronic Adherence Data Improves Viral Prediction and May Provide Strategies for Selective HIV RNA MonitoringMaya L Petersen, Erin LeDell, Joshua Schwab, et al.
Journal of Virology|May 8, 2020
Differential Vpu-Mediated CD4 and Tetherin Downregulation Functions among Major HIV-1 Group M SubtypesGisele Umviligihozo, Kyle D Cobarrubias, Sandali Chandrarathna, et al.
Journal of the International AIDS Society|September 30, 2011
Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009Elvin H Geng, Peter W Hunt, Lameck O Diero, et al.
Pageof 39